• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

母胎医学会特别声明:严重高血压产后及时随访的质量指标。

Society for Maternal-Fetal Medicine Special Statement: Quality metric for timely postpartum follow-up after severe hypertension.

出版信息

Am J Obstet Gynecol. 2022 Sep;227(3):B2-B8. doi: 10.1016/j.ajog.2022.05.045. Epub 2022 May 27.

DOI:10.1016/j.ajog.2022.05.045
PMID:35644249
Abstract

Hypertensive disorders of pregnancy are a leading cause of maternal morbidity and mortality. Because postpartum exacerbation of severe hypertension is common, the American College of Obstetricians and Gynecologists recommends that patients with severe hypertension during the childbirth hospitalization be seen within 72 hours after discharge. In this statement, the Society for Maternal-Fetal Medicine proposes a uniform metric reflecting the rate of timely postpartum follow-up of patients with severe hypertension. The metric is designed to be measured using automated calculations based on billing codes derived from claims data. The metric can be used in quality improvement projects to increase the rate of timely follow-up in patients with severe hypertension during the childbirth hospitalization. Suggested steps for implementing such a project are outlined.

摘要

妊娠高血压疾病是孕产妇发病率和死亡率的主要原因。由于产后严重高血压恶化较为常见,美国妇产科医师学会建议在分娩住院期间患有严重高血压的患者在出院后 72 小时内进行随访。在本声明中,母胎医学学会提出了一个统一的指标,反映了严重高血压患者产后及时随访的比例。该指标旨在通过使用从索赔数据中提取的计费代码进行自动计算来进行测量。该指标可用于质量改进项目,以提高分娩住院期间严重高血压患者的及时随访率。概述了实施此类项目的建议步骤。

相似文献

1
Society for Maternal-Fetal Medicine Special Statement: Quality metric for timely postpartum follow-up after severe hypertension.母胎医学会特别声明:严重高血压产后及时随访的质量指标。
Am J Obstet Gynecol. 2022 Sep;227(3):B2-B8. doi: 10.1016/j.ajog.2022.05.045. Epub 2022 May 27.
2
Society for Maternal-Fetal Medicine Special Statement: Quality metric on the rate of postpartum diabetes screening after pregnancies with gestational diabetes mellitus.母胎医学协会特别声明:关于妊娠期糖尿病妊娠后产后糖尿病筛查率的质量指标。
Am J Obstet Gynecol. 2023 Apr;228(4):B2-B9. doi: 10.1016/j.ajog.2022.12.315. Epub 2022 Dec 28.
3
Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.新的足月前子痫定义对不良母婴围生结局识别的影响。
Am J Obstet Gynecol. 2021 May;224(5):518.e1-518.e11. doi: 10.1016/j.ajog.2020.11.004. Epub 2020 Nov 6.
4
Immediate postpartum management of patients with severe hypertensive disorders of pregnancy: pathophysiology guiding practice.严重妊娠高血压疾病患者的产后即刻管理:病理生理学指导实践。
J Matern Fetal Neonatal Med. 2022 May;35(10):2009-2019. doi: 10.1080/14767058.2020.1776251. Epub 2020 Jun 10.
5
The impact of the definition of preeclampsia on disease diagnosis and outcomes: a retrospective cohort study.子痫前期定义对疾病诊断及结局的影响:一项回顾性队列研究
Am J Obstet Gynecol. 2021 Feb;224(2):217.e1-217.e11. doi: 10.1016/j.ajog.2020.08.019. Epub 2020 Aug 12.
6
Society for Maternal-Fetal Medicine Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention-quality metric and opportunities for quality improvement.母胎医学会特别声明:预防子痫前期的预防性低剂量阿司匹林——质量指标和质量改进机会。
Am J Obstet Gynecol. 2023 Aug;229(2):B2-B9. doi: 10.1016/j.ajog.2023.04.039. Epub 2023 May 4.
7
Hypertension and pregnancy.高血压与妊娠
Emerg Med Clin North Am. 2012 Nov;30(4):903-17. doi: 10.1016/j.emc.2012.08.006.
8
Using ultrasound and angiogenic markers from a 19- to 23-week assessment to inform the subsequent diagnosis of preeclampsia.利用 19 至 23 周评估的超声和血管生成标志物来辅助子痫前期的后续诊断。
Am J Obstet Gynecol. 2022 Aug;227(2):294.e1-294.e11. doi: 10.1016/j.ajog.2022.03.007. Epub 2022 Mar 9.
9
Evaluating the maternal and perinatal sequelae of severe gestational hypertension.评估严重妊娠期高血压的母婴围生期结局。
Am J Obstet Gynecol MFM. 2021 Jan;3(1):100280. doi: 10.1016/j.ajogmf.2020.100280. Epub 2020 Nov 26.
10
Antihypertensives in Pregnancy.妊娠期抗高血压药物
Obstet Gynecol Clin North Am. 2023 Mar;50(1):39-78. doi: 10.1016/j.ogc.2022.10.008.

引用本文的文献

1
Safety and Risks of Antihypertensive Medications During Breastfeeding: A Review of Current Guidelines.母乳喂养期间抗高血压药物的安全性与风险:现行指南综述
J Clin Med. 2025 May 26;14(11):3722. doi: 10.3390/jcm14113722.
2
Implementation and Integration of a Hospital-Wide Postpartum Hypertension Clinic.全院产后高血压诊所的实施与整合
Womens Health Rep (New Rochelle). 2025 Feb 12;6(1):169-177. doi: 10.1089/whr.2024.0149. eCollection 2025.
3
Hypertension Management in Women With a Multidisciplinary Approach.采用多学科方法管理女性高血压
Mayo Clin Proc. 2025 Mar;100(3):514-533. doi: 10.1016/j.mayocp.2024.10.005. Epub 2024 Dec 29.
4
Perinatal Remote Blood Pressure Monitoring.围产期远程血压监测。
Obstet Gynecol. 2024 Sep 1;144(3):339-345. doi: 10.1097/AOG.0000000000005690. Epub 2024 Jul 25.
5
Building Capacity of Community Health Centers to Improve the Provision of Postpartum Care Services Through Data-Driven Health Information Technology and Innovation.通过数据驱动的健康信息技术和创新,提升社区卫生中心的能力,以改善产后护理服务的提供。
J Womens Health (Larchmt). 2024 Sep;33(9):1140-1150. doi: 10.1089/jwh.2024.0364. Epub 2024 Jul 11.
6
Association Between Hispanic Ethnicity and Engagement in a Remote Postpartum Blood Pressure Monitoring Programs: Secondary Analysis of a Pilot Randomized Trial.西班牙裔族群与参与远程产后血压监测项目之间的关联:一项初步随机试验的二次分析。
R I Med J (2013). 2024 Jun 3;107(6):17-18.
7
Report from a text-based blood pressure monitoring prospective cohort trial among postpartum women with hypertensive disorders of pregnancy.一项基于文本的妊娠期高血压疾病产后女性血压监测前瞻性队列试验的报告。
BMC Pregnancy Childbirth. 2024 May 3;24(1):340. doi: 10.1186/s12884-024-06511-1.
8
Evaluating Racial Disparities in Implementation and Monitoring of a Remote Blood Pressure Program in a Pregnant Population-A Retrospective Cohort Study.评估孕妇远程血压项目实施与监测中的种族差异——一项回顾性队列研究
Ochsner J. 2024 Spring;24(1):22-30. doi: 10.31486/toj.23.0111.